HBIO

Harvard Biosci

• Reuters·04/01 13:44

  Harvard Bioscience CFO Mark Frost acquires $25,000 common shares

• Reuters·03/18 18:13

  Harvard Bioscience Director Stephen J DeNelsky Acquires USD 48,700 in Common Shares

• Reuters·03/18 11:32

  Harvard Bioscience Director William Snider Acquires USD 103,000 of Common Shares

• Reuters·03/17 21:57

  Harvard Bioscience CEO John D Duke acquires USD 25,050 of common shares

• Dow Jones·03/16 13:35

  Harvard Bioscience Is Maintained at Speculative Buy by Benchmark

• Dow Jones·03/16 13:35

  Harvard Bioscience Price Target Raised to $6.00/Share From $0.60 by Benchmark

• Benzinga·03/16 13:26

  Benchmark Maintains Speculative Buy on Harvard Bioscience, Raises Price Target to $6

• Reuters·03/16 11:17

  HARVARD BIOSCIENCE INC <HBIO.O>: BENCHMARK RAISES TARGET PRICE TO $6 FROM $0.60

• Reuters·03/16 10:00

  U.S. RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Cogent Biosciences, Summit Therapeutics

• Dow Jones·03/13 12:58

  Harvard Bioscience Is Maintained at Speculative Buy by Benchmark

• Dow Jones·03/13 12:58

  Harvard Bioscience Price Target Cut to $0.60/Share From $2.00 by Benchmark

• Benzinga·03/13 12:48

  Benchmark Maintains Speculative Buy on Harvard Bioscience, Lowers Price Target to $0.6

• Reuters·03/12 11:41

  Harvard Bioscience Q4 revenue falls 3%, reports net loss

• Dow Jones·03/12 11:37

  *Harvard Bioscience Sees FY26 Adj EBITDA Growth Between 6% and 10% >HBIO

• Dow Jones·03/12 11:36

  *Harvard Bioscience Sees FY26 Revenue Growth Between 2% and 4% >HBIO